Literature DB >> 21173178

Porphyromonas gingivalis cysteine proteinase inhibition by kappa-casein peptides.

Elena C Y Toh1, Stuart G Dashper, N Laila Huq, Troy J Attard, Neil M O'Brien-Simpson, Yu-Yen Chen, Keith J Cross, David P Stanton, Rita A Paolini, Eric C Reynolds.   

Abstract

Porphyromonas gingivalis is a major pathogen associated with chronic periodontitis, an inflammatory disease of the supporting tissues of the teeth. The Arg-specific (RgpA/B) and Lys-specific (Kgp) cysteine proteinases of P. gingivalis are major virulence factors for the bacterium. In this study κ-casein(109-137) was identified in a chymosin digest of casein as an inhibiting peptide of the P. gingivalis proteinases. The peptide was synthesized and shown to inhibit proteolytic activity associated with P. gingivalis whole cells, purified RgpA-Kgp proteinase-adhesin complexes, and purified RgpB proteinase. The peptide κ-casein(109-137) exhibited synergism with Zn(II) against both Arg- and Lys-specific proteinases. The active region for inhibition was identified as κ-casein(117-137) using synthetic peptides. Kinetic studies revealed that κ-casein(109-137) inhibits in an uncompetitive manner. A molecular model based on the uncompetitive action and its synergistic ability with Zn(II) was developed to explain the mechanism of inhibition. Preincubation of P. gingivalis with κ-casein(109-137) significantly reduced lesion development in a murine model of infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21173178      PMCID: PMC3067070          DOI: 10.1128/AAC.00466-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

Review 1.  Periodontal diseases and tooth loss.

Authors:  R C Oliver; L J Brown
Journal:  Periodontol 2000       Date:  1993-06       Impact factor: 7.589

2.  HOMSTRAD: a database of protein structure alignments for homologous families.

Authors:  K Mizuguchi; C M Deane; T L Blundell; J P Overington
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

3.  Microbial complexes in subgingival plaque.

Authors:  S S Socransky; A D Haffajee; M A Cugini; C Smith; R L Kent
Journal:  J Clin Periodontol       Date:  1998-02       Impact factor: 8.728

4.  The global burden of oral diseases and risks to oral health.

Authors:  Poul Erik Petersen; Denis Bourgeois; Hiroshi Ogawa; Saskia Estupinan-Day; Charlotte Ndiaye
Journal:  Bull World Health Organ       Date:  2005-09-30       Impact factor: 9.408

5.  Mushroom tyrosinase inhibition by two potent uncompetitive inhibitors.

Authors:  F Karbassi; A A Saboury; M T Hassan Khan; M Iqbal Choudhary; Z S Saifi
Journal:  J Enzyme Inhib Med Chem       Date:  2004-08       Impact factor: 5.051

Review 6.  Micelle stability: kappa-casein structure and function.

Authors:  L K Creamer; J E Plowman; M J Liddell; M H Smith; J P Hill
Journal:  J Dairy Sci       Date:  1998-11       Impact factor: 4.034

7.  Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model.

Authors:  L Kesavalu; S C Holt; J L Ebersole
Journal:  Oral Microbiol Immunol       Date:  1998-12

8.  A cell-associated protein complex of Porphyromonas gingivalis W50 composed of Arg- and Lys-specific cysteine proteinases and adhesins.

Authors:  Peter S Bhogal; Nada Slakeski; Eric C Reynolds
Journal:  Microbiology (Reading)       Date:  1997-07       Impact factor: 2.777

9.  Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors.

Authors:  Tomoko Kadowaki; Atsuyo Baba; Naoko Abe; Ryosuke Takii; Munetaka Hashimoto; Takayuki Tsukuba; Shinji Okazaki; Yoshimitsu Suda; Tetsuji Asao; Kenji Yamamoto
Journal:  Mol Pharmacol       Date:  2004-09-10       Impact factor: 4.436

10.  Histatin 5 is a substrate and not an inhibitor of the Arg- and Lys-specific proteinases of Porphyromonas gingivalis.

Authors:  N M O'Brien-Simpson; S G Dashper; E C Reynolds
Journal:  Biochem Biophys Res Commun       Date:  1998-09-18       Impact factor: 3.575

View more
  6 in total

1.  Diagnostic evaluation of a nanobody with picomolar affinity toward the protease RgpB from Porphyromonas gingivalis.

Authors:  Peter Durand Skottrup; Paul Leonard; Jakub Zbigniew Kaczmarek; Florian Veillard; Jan Johannes Enghild; Richard O'Kennedy; Aneta Sroka; Rasmus Prætorius Clausen; Jan Potempa; Erik Riise
Journal:  Anal Biochem       Date:  2011-04-20       Impact factor: 3.365

2.  Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Authors:  Stuart G Dashper; Yu Pan; Paul D Veith; Yu-Yen Chen; Elena C Y Toh; Sze Wei Liu; Keith J Cross; Eric C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

3.  Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis.

Authors:  Bjarne Vincents; Arndt Guentsch; Dominika Kostolowska; Ulrich von Pawel-Rammingen; Sigrun Eick; Jan Potempa; Magnus Abrahamson
Journal:  FASEB J       Date:  2011-07-18       Impact factor: 5.191

4.  Porphyromonas gingivalis Uses Specific Domain Rearrangements and Allelic Exchange to Generate Diversity in Surface Virulence Factors.

Authors:  Stuart G Dashper; Helen L Mitchell; Christine A Seers; Simon L Gladman; Torsten Seemann; Dieter M Bulach; P Scott Chandry; Keith J Cross; Steven M Cleal; Eric C Reynolds
Journal:  Front Microbiol       Date:  2017-01-26       Impact factor: 5.640

5.  Propeptide-mediated inhibition of cognate gingipain proteinases.

Authors:  N Laila Huq; Christine A Seers; Elena C Y Toh; Stuart G Dashper; Nada Slakeski; Lianyi Zhang; Brent R Ward; Vincent Meuric; Dina Chen; Keith J Cross; Eric C Reynolds
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

Review 6.  Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases.

Authors:  Ingar Olsen; Jan Potempa
Journal:  J Oral Microbiol       Date:  2014-08-18       Impact factor: 5.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.